Transcatheter Aortic Valve Replacement Associated With Fibrin-Associated Large B-Cell Lymphoma

经导管主动脉瓣置换术与纤维蛋白相关大B细胞淋巴瘤相关

阅读:1

Abstract

BACKGROUND: Fibrin-associated large B-cell lymphoma (FA-LBCL) is a rare disorder, but its role in transcatheter valve failure is unknown. This report describes the first documented case of FA-LBCL in a transcatheter aortic valve. FIRST-IN-HUMAN/EARLY REPORTS SUMMARY: A 62-year-old man with a prior transcatheter aortic valve replacement presented with symptomatic severe aortic stenosis. Histopathologic analysis of the explanted valve revealed FA-LBCL as the primary cause of valve failure. DISCUSSION: This case established a neoplastic process as a cause of structural valve degeneration (SVD) in transcatheter valves. It highlights that FA-LBCL should be included in the differential diagnosis of transcatheter aortic valve replacement failure, for which surgical explantation can be both diagnostic and curative. NOVELTY: This is the first report that documents FA-LBCL causing SVD of a transcatheter bioprosthetic valve. TAKE-HOME MESSAGES: FA-LBCL represents a cause of SVD in transcatheter bioprosthetic valves. This diagnosis should be considered in cases of premature valve failure.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。